Artículo
Alamino, V.A.; Montesinos, M.M.; Rabinovich, G.A.; Pellizas, C.G. "The thyroid hormone triiodothyronine reinvigorates dendritic cells and potentiates anti-tumor immunity" (2016) OncoImmunology. 5(1)
Estamos trabajando para incorporar este artículo al repositorio
Consulte la política de Acceso Abierto del editor
Abstract:
Dendritic cell (DC) cancer vaccines have shown limited clinical benefit. Thus, the identification of signals and molecular pathways that potentiate the immunogenicity of DCs has become a major challenge in cancer research. Our studies demonstrate that triiodothyronine endows DCs with enhanced ability to stimulate cytotoxic T-cell responses with implications in DC-based immunotherapy. © 2016 Taylor & Francis Group, LLC.
Registro:
| Documento: | Artículo |
| Título: | The thyroid hormone triiodothyronine reinvigorates dendritic cells and potentiates anti-tumor immunity |
| Autor: | Alamino, V.A.; Montesinos, M.M.; Rabinovich, G.A.; Pellizas, C.G. |
| Filiación: | Centro de Investigaciones en Bioquímica Clínica e Inmunología (CIBICI-CONICET), Departamento de Bioquímica Clínica, Universidad Nacional de Córdoba, Córdoba, Argentina Laboratorio de Inmunopatología, Instituto de Biología y Medicina Experimental (IBYME-CONICET), Departamento de Química Biológica, Universidad de Buenos Aires, Buenos Aires, Argentina |
| Palabras clave: | Cancer vaccination; Dendritic cell; Immunotherapy; Thyroid hormone; Triiodothyronine; cancer vaccine; gamma interferon; liothyronine; Article; cell differentiation; cross presentation; dendritic cell; immune response; immunogenicity; nonhuman; protein expression; signal transduction; tumor growth; tumor immunity |
| Año: | 2016 |
| Volumen: | 5 |
| Número: | 1 |
| DOI: | http://dx.doi.org/10.1080/2162402X.2015.1064579 |
| Título revista: | OncoImmunology |
| Título revista abreviado: | OncoImmunology |
| ISSN: | 21624011 |
| CAS: | gamma interferon, 82115-62-6; liothyronine, 6138-47-2, 6893-02-3 |
| Registro: | https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_21624011_v5_n1_p_Alamino |
Referencias:
- Butts, C.L., Sternberg, E.M., Neuroendocrine factors alter host defense by modulating immune function (2008) Cell Immunol, 252, pp. 7-15. , http://dx.doi.org/10.1016/j.cellimm.2007.09.009, PMID:18329009
- Palucka, K., Banchereau, J., Cancer immunotherapy via dendritic cells (2012) Nat Rev Cancer, 12, pp. 265-277. , http://dx.doi.org/10.1038/nrc3258, PMID:22437871
- Kim, W.G., Cheng, S.Y., Thyroid hormone receptors and cancer (2013) Biochim Biophys Acta, 1830, pp. 3928-3936. , http://dx.doi.org/10.1016/j.bbagen.2012.04.002, PMID:22507269
- De Vito, P., Incerpi, S., Pedersen, J.Z., Luly, P., Davis, F.B., Davis, P.J., Thyroid hormones as modulators of immune activities at the cellular level (2011) Thyroid, 21, pp. 879-890. , http://dx.doi.org/10.1089/thy.2010.0429, PMID:21745103
- Mascanfroni, I., Montesinos Mdel, M., Susperreguy, S., Cervi, L., Ilarregui, J.M., Ramseyer, V.D., Masini-Repiso, A.M., Pellizas, C.G., Control of dendritic cell maturation and function by triiodothyronine (2008) FASEB J, 22, pp. 1032-1042. , http://dx.doi.org/10.1096/fj.07-8652com, PMID:17991732
- Mascanfroni, I.D., Montesinos Mdel, M., Alamino, V.A., Susperreguy, S., Nicola, J.P., Ilarregui, J.M., Masini-Repiso, A.M., Pellizas, C.G., Nuclear factor (NF)-kappaB-dependent thyroid hormone receptor beta1 expression controls dendritic cell function via Akt signaling (2010) J Biol Chem, 285, pp. 9569-9582. , http://dx.doi.org/10.1074/jbc.M109.071241, PMID:20018842
- Montesinos, M.M., Alamino, V.A., Mascanfroni, I.D., Susperreguy, S., Gigena, N., Masini-Repiso, A.M., Rabinovich, G.A., Pellizas, C.G., Dexamethasone counteracts the immunostimulatory effects of triiodothyronine (T3) on dendritic cells (2012) Steroids, 77, pp. 67-76. , http://dx.doi.org/10.1016/j.steroids.2011.10.006, PMID:22056479
- Alamino, V.A., Mascanfroni, I.D., Montesinos, M.M., Gigena, N., Donadio, A.C., Blidner, A.G., Milotich, S.I., Rabinovich, G.A., Antitumor responses stimulated by dendritic cells are improved by triiodothyronine binding to the thyroid hormone receptor beta (2015) Cancer Res, 75, pp. 1265-1274. , http://dx.doi.org/10.1158/0008-5472.CAN-14-1875, PMID:25672979
- Park, D., Lapteva, N., Seethammagari, M., Slawin, K.M., Spencer, D.M., An essential role for Akt1 in dendritic cell function and tumor immunotherapy (2006) Nat Biotechnol, 24, pp. 1581-1590. , http://dx.doi.org/10.1038/nbt1262, PMID:17143278
- Sallusto, F., Lanzavecchia, A., Understanding dendritic cell and Tlymphocyte traffic through the analysis of chemokine receptor expression (2000) Immunol Rev, 177, pp. 134-140. , http://dx.doi.org/10.1034/j.1600-065X.2000.17717.x, PMID:11138771
Citas:
---------- APA ----------
Alamino, V.A., Montesinos, M.M., Rabinovich, G.A. & Pellizas, C.G. (2016) . The thyroid hormone triiodothyronine reinvigorates dendritic cells and potentiates anti-tumor immunity. OncoImmunology, 5(1).http://dx.doi.org/10.1080/2162402X.2015.1064579
---------- CHICAGO ----------
Alamino, V.A., Montesinos, M.M., Rabinovich, G.A., Pellizas, C.G. "The thyroid hormone triiodothyronine reinvigorates dendritic cells and potentiates anti-tumor immunity" . OncoImmunology 5, no. 1 (2016).http://dx.doi.org/10.1080/2162402X.2015.1064579
---------- MLA ----------
Alamino, V.A., Montesinos, M.M., Rabinovich, G.A., Pellizas, C.G. "The thyroid hormone triiodothyronine reinvigorates dendritic cells and potentiates anti-tumor immunity" . OncoImmunology, vol. 5, no. 1, 2016.http://dx.doi.org/10.1080/2162402X.2015.1064579
---------- VANCOUVER ----------
Alamino, V.A., Montesinos, M.M., Rabinovich, G.A., Pellizas, C.G. The thyroid hormone triiodothyronine reinvigorates dendritic cells and potentiates anti-tumor immunity. OncoImmunology. 2016;5(1).http://dx.doi.org/10.1080/2162402X.2015.1064579
